Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dafra Pharma is a European pharmaceutical company dedicated to providing high-quality, affordable medicines specifically tailored for the Sub-Saharan African market. Founded in 1997 with a primary focus on anti-malarial treatments, the company has since expanded its portfolio to include a wide range of therapeutic areas such as cardiology, gastroenterology, and infectious diseases. Dafra Pharma operates through an extensive distribution network across Africa, emphasizing scientific training for its sales force and partnerships with local healthcare providers. The company is known for its commitment to European quality standards while addressing the unique medical needs and challenges of the African population.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DAF.